EU & UK - What's My Route to Market? Class I to Class III | LSI Europe '22

Описание к видео EU & UK - What's My Route to Market? Class I to Class III | LSI Europe '22

A critical analysis of the routes to market for the EU and UK, and the requirements around clinical evaluation. Discussion about Notified or Approved body input and critical post market considerations. This session is vital for anyone looking to build an understanding of they key principles and requirements, smoothing the regulatory path, and avoiding pitfalls along the way.

Moderated by Edmund White, Global Chief Commercial Officer, ECLEVAR

Joined by Panelists:
Camilla Fleetcroft, VP Clinical & Regulatory Affairs, ECLEVAR
Florence Longueville, HEad of Clinical Operations, ECELVAR

Комментарии

Информация по комментариям в разработке